2021
DOI: 10.3390/ijms222313106
|View full text |Cite
|
Sign up to set email alerts
|

Long-Term Effects of Neural Precursor Cell Transplantation on Secondary Injury Processes and Functional Recovery after Severe Cervical Contusion-Compression Spinal Cord Injury

Abstract: Cervical spinal cord injury (SCI) remains a devastating event without adequate treatment options despite decades of research. In this context, the usefulness of common preclinical SCI models has been criticized. We, therefore, aimed to use a clinically relevant animal model of severe cervical SCI to assess the long-term effects of neural precursor cell (NPC) transplantation on secondary injury processes and functional recovery. To this end, we performed a clip contusion-compression injury at the C6 level in 40… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 14 publications
(10 citation statements)
references
References 84 publications
(120 reference statements)
0
7
0
Order By: Relevance
“…NSC survival was lower when NSCs were transplanted in the acute phase of injury (1%) compared to the subacute one (6%) [ 48 , 49 ]. This deficiency could be caused by early immunoreaction events at the lesion site, which are toxic to implanted cells [ 50 , 51 ]. Strategies for protecting implanted NSCs from the harsh SCI lesion environment include delivering NSCs inside biomaterials (such as the PCS utilized in this study) and providing anti-apoptotic support via small molecule compounds or biologics.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…NSC survival was lower when NSCs were transplanted in the acute phase of injury (1%) compared to the subacute one (6%) [ 48 , 49 ]. This deficiency could be caused by early immunoreaction events at the lesion site, which are toxic to implanted cells [ 50 , 51 ]. Strategies for protecting implanted NSCs from the harsh SCI lesion environment include delivering NSCs inside biomaterials (such as the PCS utilized in this study) and providing anti-apoptotic support via small molecule compounds or biologics.…”
Section: Discussionmentioning
confidence: 99%
“…Another major challenge of NSC-based SCI treatments is that NSCs differentiate mostly into glial cells and poorly towards neurons, as the lesion environment is unfavorable for neuronal differentiation [ 49 , 51 , 53 , 54 , 55 ]. Significant research has attempted to guide the fate of implanted NSCs using biomaterials and growth factors that enhance neuronal survival and differentiation [ 55 ].…”
Section: Discussionmentioning
confidence: 99%
“…In the context of growing evidence for the relevance of endogenous NPCs in response to CNS injuries [ 10 , 38 , 39 ], Shh might thus have the potential to improve endogenous neuroregeneration by modulation of NPC niches in, e.g., the spinal cord. Moreover, given the recent interest in stem cell transplantation as a therapeutic option after SCI [ 26 , 40 , 41 , 42 ], whereby NPCs play a dominant role [ 13 , 21 , 43 , 44 ], a better understanding of the interactions between Shh and the proliferation/differentiation of NPCs might have implications for such cellular-based treatments as well. Of note, a common problem of current NPC-transplantation strategies is the low survival of the cell graft which might be improved by synergistic Shh-treatment [ 45 , 46 ].…”
Section: Discussionmentioning
confidence: 99%
“…Before clinical trials, studies of stem cell trans plantation were conducted on animal disease models to examine the safety and efficiency of stem cell therapy. Recently, various studies have been carried out using primary NS/PCs, neural precursors, immortalized neural stem cell lines, iPSC-derived NS/PCs, and directly reprogrammed neural precursor cells to treat spinal cord injury (SCI)[ 189 , 190 ], AD[ 191 , 192 ], PD[ 193 - 195 ], Huntington’s disease (HD)[ 196 , 197 ] and ALS[ 198 ] in animal models, and the symptoms of those diseases were relieved to some extent. For instance, the long-term selective stimulation of hM3Dq-expressing human iPSCs (hiPSCs)-derived NS/PCs enhanced their BDNF secretion, neuron-to-neuron interactions and synaptic activity in the surrounding host tissue in mouse SCI models, suggesting that enhancing neural activity and interactions with other cells in the neural circuit can be an effective way to improve the therapeutic effect of stem cell transplantation[ 199 ].…”
Section: Applications Of Induced Neuronal Cellsmentioning
confidence: 99%